K. Kugler

发表

Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.

Ronald N. Jones, M. Pfaller, R. Jones, 1999, Diagnostic microbiology and infectious disease.

Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).

Ronald N. Jones, D. Mathai, M. Pfaller, 2001, Diagnostic microbiology and infectious disease.

Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States.

J. Duval, M. Pfaller, G. Doern, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Ronald N. Jones, M. Pfaller, G. Doern, 1999, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.

M. Pfaller, G. Doern, R. Jones, 1998, Diagnostic microbiology and infectious disease.

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997).

Ronald N. Jones, M. Pfaller, R. Jones, 2000, Diagnostic microbiology and infectious disease.

In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

G. Doern, A. Brueggemann, K. Kugler, 1997, Antimicrobial agents and chemotherapy.

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America).

M. Pfaller, G. Doern, R. Jones, 1999, Diagnostic microbiology and infectious disease.

Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media.

R. Jones, S. Marshall, K. Kugler, 2000, International journal of antimicrobial agents.

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

M. Pfaller, G. Doern, R. Jones, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Ronald N. Jones, M. Pfaller, G. Doern, 1998, Antimicrobial Agents and Chemotherapy.

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.

M. Pfaller, G. Doern, D. Diekema, 2000, International journal of antimicrobial agents.

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.

M. Pfaller, G. Doern, D. Diekema, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.

M. Pfaller, G. Doern, R. Jones, 1999, Diagnostic microbiology and infectious disease.

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997).

Ronald N. Jones, M. Pfaller, M. Beach, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): case reports from the SENTRY antimicrobial surveillance program.

R. Jones, M. Wilson, G. Denys, 2000, Diagnostic microbiology and infectious disease.

Gatifloxacin Susceptibility Testing Interpretive Criteria and Quality Control Guidelines for Dilution and Disk Diffusion Methods

M. Pfaller, G. Doern, R. Jones, 1999, Drugs.

Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-μg) diffusion methods

Ronald N. Jones, M. Pfaller, D. Biedenbach, 1999 .

Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms.

R. Jones, D. Biedenbach, K. Kugler, 1999, Diagnostic microbiology and infectious disease.

Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program.

Jones, Pfaller, G. Doern, 1999, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.